Aquestive Therapeutics Announces Expert Allergy Scientific Advisory Board
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives, announced today the establishment of a Scientific Advisory Board comprised of eight allergy experts. Jay Lieberman, MD, is currently an Associate Professor at the University of Tennessee Health Science… Read More